Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
euphol
Cat. No.:
0225LY-1378
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Euphol is a tetracyclic triterpene alcohol recognized for its broad pharmacological profile and notable anti-inflammatory actions.
Synonym:
Euphadienol; 514-47-6; (+)-Euphol; Eupha-8,24-dienol; (20R)-(+)-triucalla-8,24-diene-3beta-ol; 5alpha-Eupha-8,24-dien-3beta-ol; Euphol (6CI); (3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; Alpha-Euphol; (s)-euphol; (+)-alpha-Euphol
CAS No.:
514-47-6
Compound CID:
441678
Formula:
C30H50
Formula Weight:
426.72
Specification
Relative Density:
0.98 g/cm3 at 20°C.
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Euphol can be used in pharmacological studies to explore its anti-inflammatory and potential anti-tumor properties in skin cancer models.
Library Information
Target:
MAGL
Receptor:
MAGL
Pathways:
Metabolism
Plate Number:
AOCL-18
Plate Location:
f11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
4.27 mg/mL; 10.01 mM
